2-(3-((tert-Butoxycarbonyl)amino)pyrrolidin-1-yl)acetic acid

Catalog No. :
ACBVXW149
CAS No. :
261715-71-3
Molecular Formula :
C11H20N2O4
Molecular Weight :
244.29

IUPAC Name:2-(3-((tert-butoxycarbonyl)amino)pyrrolidin-1-yl)acetic acid

2-(3-((tert-Butoxycarbonyl)amino)pyrrolidin-1-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$61.00Login to see priceIn stockInquiry
100mg95%$87.00Login to see priceIn stockInquiry
250mg95%$144.00Login to see priceIn stockInquiry
1g95%$335.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-((tert-Butoxycarbonyl)amino)pyrrolidin-1-yl)acetic acid
IUPAC Name2-(3-((tert-butoxycarbonyl)amino)pyrrolidin-1-yl)acetic acid
MDL No.MFCD01861775
Molecular FormulaC11H20N2O4
Molecular Weight244.29
SMILESO=C(O)CN1CC(NC(OC(C)(C)C)=O)CC1
InChI KeyCCVCVMIWAWLHLX-UHFFFAOYSA-N
Synonym3-(Boc-amino)-1-pyrrolidineacetic acid;2-(3-((tert-Butoxycarbonyl)amino)pyrrolidin-1-yl)acetic acid;3-(DL)-N-BOC-1-PYRROLIDINEACETIC ACID;1-Pyrrolidineacetic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-
CAS No.261715-71-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBVXW149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBVXW149 route product structure diagram
    ACBVXW149261715-71-3 In Stock
Inquiry

2. ACBVXW149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBVXW149 route product structure diagram
    ACBVXW149261715-71-3 In Stock
Inquiry

Comments (0)